Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro
- PMID: 26333304
- DOI: 10.1002/bab.1441
Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro
Abstract
O-GlcNAcylation is a monosaccharide modification by a residue of N-acetylglucosamine (GlcNAc) attached to serine or threonine moieties on nuclear and cytoplasmic proteins. O-GlcNAcylation is dynamically regulated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Increasing evidence suggests that O-GlcNAcylation is involved in a variety of human cancers. However, the exact role of O-GlcNAcylation in tumor progression remains unclear. Here, we show that O-GlcNAcylation accelerates oncogenic phenotypes of gastric cancer. First, cell models with increased or decreased O-GlcNAcylation were constructed by OGT overexpression, downregulation of OGA activity with specific inhibitor Thiamet-G, or silence of OGT. MTT assays indicated that O-GlcNAcylation increased proliferation of gastric cancer cells. Soft agar assay and Transwell assays showed that O-GlcNAcylation significantly enhanced cellular colony formation, migration, and invasion in vitro. Akt1 activity was stimulated by upregulation of phosphorylation at Ser473 mediated by elevated O-GlcNAcylation. The enhanced cell invasion by Thiamet-G treatment was suppressed by PI3K inhibitor LY294002. Although the cell invasion induced by Thiamet-G was reduced by Akt1 shRNA, it was still higher in comparison with that to the control (cells with Akt1 shRNA alone). And Akt1 overexpression promoted Thiamet-G-induced cell invasion. These results suggested that O-GlcNAcylation enhanced oncogenic phenotypes possibly partially involving PI3K/Akt signaling pathway.
Keywords: O-GlcNAcylation; PI3K/Akt; gastric cancer; invasion; migration; proliferation.
© 2015 International Union of Biochemistry and Molecular Biology, Inc.
Similar articles
-
Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.Oncotarget. 2016 Sep 20;7(38):61390-61402. doi: 10.18632/oncotarget.11359. Oncotarget. 2016. PMID: 27542217 Free PMC article.
-
O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.Onco Targets Ther. 2015 Nov 9;8:3305-13. doi: 10.2147/OTT.S82845. eCollection 2015. Onco Targets Ther. 2015. PMID: 26635480 Free PMC article.
-
Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.J Biol Chem. 2016 Sep 2;291(36):18897-914. doi: 10.1074/jbc.M116.734533. Epub 2016 Jul 11. J Biol Chem. 2016. PMID: 27402830 Free PMC article.
-
[Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology].Biol Aujourdhui. 2014;208(2):109-17. doi: 10.1051/jbio/2014015. Epub 2014 Sep 8. Biol Aujourdhui. 2014. PMID: 25190571 Review. French.
-
Essential role of O-GlcNAcylation in stabilization of oncogenic factors.Biochim Biophys Acta Gen Subj. 2019 Aug;1863(8):1302-1317. doi: 10.1016/j.bbagen.2019.04.002. Epub 2019 Apr 26. Biochim Biophys Acta Gen Subj. 2019. PMID: 31034911 Review.
Cited by
-
Effects of Acute Cold Stress on Liver O-GlcNAcylation and Glycometabolism in Mice.Int J Mol Sci. 2018 Sep 18;19(9):2815. doi: 10.3390/ijms19092815. Int J Mol Sci. 2018. PMID: 30231545 Free PMC article.
-
O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.Mol Med. 2022 Sep 14;28(1):115. doi: 10.1186/s10020-022-00544-y. Mol Med. 2022. PMID: 36104770 Free PMC article. Review.
-
Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.Oncotarget. 2016 Sep 20;7(38):61390-61402. doi: 10.18632/oncotarget.11359. Oncotarget. 2016. PMID: 27542217 Free PMC article.
-
Cross-Dysregulation of O-GlcNAcylation and PI3K/AKT/mTOR Axis in Human Chronic Diseases.Front Endocrinol (Lausanne). 2018 Oct 9;9:602. doi: 10.3389/fendo.2018.00602. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30356686 Free PMC article. Review.
-
Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.Front Endocrinol (Lausanne). 2016 May 25;7:46. doi: 10.3389/fendo.2016.00046. eCollection 2016. Front Endocrinol (Lausanne). 2016. PMID: 27252680 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous